News
Videos
Conferences
Events
Resources
Subscribe

Teresa Macarulla, M.D.

Articles by Teresa Macarulla, M.D.

Updates From a PARP Inhibitor Clinical Trial for Patients with Metastatic Pancreatic Cancer

ByTeresa Macarulla, M.D.

February 1st 2020

A subset of patients with metastatic pancreatic cancer and an inherited BRCA mutation rapidly progressed during a clinical trial of Lynparza.

Latest Updated Articles

Updates From a PARP Inhibitor Clinical Trial for Patients with Metastatic Pancreatic Cancer
Published: February 1st 2020 | Updated:

Trending on CURE

Finding Support When People Say Others Have It Worse

FDA Approves Jaypirca for Relapsed/Refractory CLL or SLL

Every FDA Oncology Approval From November 2025

Reflecting on My Sister’s Final Days After Years of Unexpected Rebounds

Breaking Down Treatment Advancements for Small Cell Lung Cancer

© 2025 MJH Life Sciences^®

All rights reserved.